awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36892821-7E0D30A3-1C32-4590-8D74-8B58B7EDAB1B
Q36892821-7E0D30A3-1C32-4590-8D74-8B58B7EDAB1B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36892821-7E0D30A3-1C32-4590-8D74-8B58B7EDAB1B
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer.
P2860
Q36892821-7E0D30A3-1C32-4590-8D74-8B58B7EDAB1B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36892821-7E0D30A3-1C32-4590-8D74-8B58B7EDAB1B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a0b2fbcfb29ac04eaf8285f220258ada5aa8dd31
P2860
Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer an